Lipocine Inc
Price
FilingsNewest: Form 4, insider tradeNov 20 →Insiders2 insiders bought $596,274 in 9 open-market buys. No sales.→HoldersSquadron 9.8%Ikarian Capital 6.2%Eversept Partners 3.6%→Financing →PeersClosest companies: MTVA, VKTX, VSTM→
From the filings
Figures
- Revenue
- $3.0Mlast 12 months
- Net income
- −$9.3Mlast 12 months
- Operating cash flow
- −$11.2Mlast 12 months
- Cash and equivalents
- $2.6Mat the last balance sheet
- Shares outstanding
- 8.2M shareson issue